BODY FLUID BIN1 AS A MARKER OF CARDIAC HEALTH
    5.
    发明公开
    BODY FLUID BIN1 AS A MARKER OF CARDIAC HEALTH 有权
    津液BIN1作为标记物时对心脏健康

    公开(公告)号:EP2630490A4

    公开(公告)日:2014-04-16

    申请号:EP11835168

    申请日:2011-10-20

    CPC classification number: G01N33/6887 G01N33/6893 G01N2800/325 G01N2800/56

    Abstract: The present disclosure provides methods involving use of BIN1 protein levels in biological fluid of a subject in evaluating cardiac health of the subject. The method provided herein may be used to predict a risk of a poor outcome in a subject. The methods also find use in evaluating subjects for assessing patients diagnosed with heart failure. These methods are also useful in assessing therapy options and efficacy of treatment in heart failure patients.

    BODY FLUID BIN1 AS A MARKER OF CARDIAC HEALTH

    公开(公告)号:CA2814702C

    公开(公告)日:2019-05-28

    申请号:CA2814702

    申请日:2011-10-20

    Abstract: The present disclosure provides methods involving use of BIN1 protein levels in biological fluid of a subject in evaluating cardiac health of the subject. The method provided herein may be used to predict a risk of a poor outcome in a subject. The methods also find use in evaluating subjects for assessing patients diagnosed with heart failure. These methods are also useful in assessing therapy options and efficacy of treatment in heart failure patients.

    BODY FLUID BIN1 AS A MARKER OF CARDIAC HEALTH

    公开(公告)号:CA2814702A1

    公开(公告)日:2012-04-26

    申请号:CA2814702

    申请日:2011-10-20

    Abstract: The present disclosure provides methods involving use of BIN1 protein levels in biological fluid of a subject in evaluating cardiac health of the subject. The method provided herein may be used to predict a risk of a poor outcome in a subject. The methods also find use in evaluating subjects for assessing patients diagnosed with heart failure. These methods are also useful in assessing therapy options and efficacy of treatment in heart failure patients.

Patent Agency Ranking